Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

US Patent 10358645 · Granted Jul 23, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of tumor suppressor gene related diseases by inhibition of natural ant2023
Treatment of tumor suppressor gene related diseases by inhibition of natural ant2023
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2022
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2022
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression an2022
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression an2022
Treatment of collagen gene related diseases by inhibition of natural antisense t2022
Treatment of collagen gene related diseases by inhibition of natural antisense t2022
Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases2021
Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases2021
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2021
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2021